Institute Of Medical Science And Research Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 5.56 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
About Institute Of Medical Science And Research
Institute Of Medical Science And Research Private Limited (IOMSARPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 1998 and has a history of 26 years and seven months. Its registered office is in Jorhat, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.56 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Sahu, Subhrajyoti Das, and Jatindra Khargharia serve as directors at the Company.
Company Details
- Location
Jorhat, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110AS1998PTC005447
- Company No.
005447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 1998
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Institute Of Medical Science And Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhrajyoti Das  | Managing Director | 30-Jun-1998 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Sahu | Director | 12-Aug-1999 | Current |
| Jatindra Khargharia | Director | 12-Aug-1999 | Current |
Financial Performance of Institute Of Medical Science And Research.
Institute Of Medical Science And Research Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Institute Of Medical Science And Research?
In 2015, Institute Of Medical Science And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Institute Of Medical Science And Research?
Unlock and access historical data on people associated with Institute Of Medical Science And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Medical Science And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Medical Science And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
